Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers

NCT03604653 · clinicaltrials.gov ↗

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Stomach Cancer
Colorectal Cancer
Appendiceal Cancer
Ovarian Cancer
Uterine Cancer
Cervical Cancer
Fallopian Tube Cancer
Primary Peritoneal Carcinoma

Interventions

DEVICE: HIPEC
DRUG: Mitomycin c
DRUG: CDDP 50
DRUG: CDDP 75
DRUG: Doxorubicin

Sponsor

Holy Name Medical Center, Inc.